Placeholder Banner

BIO Applauds MLP Parity Act, Thanks Senate and House Sponsors

October 25, 2017

The Biotechnology Innovation Organization (BIO) today thanked Senators Chris Coons (D-DE) and Jerry Moran (R-KS) and Representatives Ted Poe (R-TX) and Mike Thompson (D-CA) for reintroducing the Master Limited Partnerships Parity Act of 2017. This bipartisan bill would level the playing field in the tax code by giving investors in renewable energy projects access to a decades-old corporate structure with a tax advantage now available only to fossil fuel projects.

Brent Erickson, Executive Vice President of BIO’s Industrial & Environmental Section, stated:

“The Master Limited Partnership Parity Act will help U.S. renewable chemical and advanced biofuel companies compete for investment dollars. The global market for biobased products is projected to double by 2024. This legislation can help U.S. producers capture their fair share of that economic growth, revitalize the domestic manufacturing sector, and create new jobs and economic opportunities. We are especially pleased that the legislation captures the rapid growth and new classes of renewable chemicals that U.S. companies are developing, including those that reuse captured carbon.”

Discover More
WASHINGTON, DC, April 8, 2025 – Today, the National Security Commission on Emerging Biotechnology (NSCEB), a bipartisan legislative commission established by Congress, issued its much-anticipated report detailing how the United States risks…
John Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement regarding the resignation of Peter Marks from the FDA: “Under the extraordinary leadership of Dr. Peter Marks, the FDA…
WASHINGTON (March 26, 2025) -- Today, the Biotechnology Innovation Organization (BIO) released results from a membership survey that underscores the significant, global integration of the biomedical supply chain. According to the findings, nearly 90…